MedPath

Weill Medical College Of Cornell University

Weill Medical College Of Cornell University logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1865-01-01
Employees
-
Market Cap
-
Website
http://weill.cornell.edu

Using CERS to Optimize Quality of Life for Persons With Diabetes and Chronic Pain

Not Applicable
Completed
Conditions
Diabetes Mellitus
Chronic Pain
Interventions
Behavioral: General Health Program
Behavioral: Living Healthy
First Posted Date
2015-09-02
Last Posted Date
2016-04-28
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
230
Registration Number
NCT02538055

Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML

Phase 2
Terminated
Conditions
Acute Myeloid Leukemia (AML)
Interventions
First Posted Date
2015-08-25
Last Posted Date
2018-06-15
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
13
Registration Number
NCT02532010
Locations
🇺🇸

Weill Cornell Medical College, New York, New York, United States

Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media

Not Applicable
Terminated
Conditions
Infertility
Interventions
Other: embryo culture in buffered media
First Posted Date
2015-08-19
Last Posted Date
2017-05-01
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
13
Registration Number
NCT02527642
Locations
🇺🇸

Center fo Reproductive Medicine, New York, New York, United States

BiRd vs. Rd as Initial Therapy in Multiple Myeloma

Phase 3
Terminated
Conditions
Multiple Myeloma
Interventions
First Posted Date
2015-08-06
Last Posted Date
2023-06-05
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
12
Registration Number
NCT02516696
Locations
🇺🇸

University of Colorado - Anschutz Cancer Center, Aurora, Colorado, United States

🇺🇸

Weill Cornell Medical College, New York, New York, United States

Fertility Preservation- Oncology Treatment Effects and Psychological Impact

Terminated
Conditions
Cancer
First Posted Date
2015-08-05
Last Posted Date
2021-10-29
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
2
Registration Number
NCT02515916
Locations
🇺🇸

Ronald O. Perelmand and Claudia Cohen Center for Reproductive Medicine, New York, New York, United States

Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)

Phase 1
Completed
Conditions
Ulcerative Colitis
Interventions
Biological: Fecal Microbiota Transplantation
First Posted Date
2015-08-05
Last Posted Date
2018-02-22
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
20
Registration Number
NCT02516384
Locations
🇺🇸

Weill Cornell Medical College, New York, New York, United States

IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia

Phase 2
Terminated
Conditions
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Interventions
Biological: haplo-identical cells (donor)
Biological: umbilical cord blood unit (CBU)
First Posted Date
2015-07-24
Last Posted Date
2024-02-13
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
43
Registration Number
NCT02508324
Locations
🇺🇸

Weill Cornell Medical College, New York, New York, United States

Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

Phase 2
Completed
Conditions
Leukemia, Erythroblastic, Acute
Myelodysplastic Syndromes
Interventions
First Posted Date
2015-07-14
Last Posted Date
2021-09-22
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
40
Registration Number
NCT02497404
Locations
🇺🇸

Weill Cornell Medical College, New York, New York, United States

Delayed Cord Clamping in Preterm Neonates

Not Applicable
Completed
Conditions
Delayed Separation of Umbilical Cord
Placental Transfusion
Premature Birth of Newborn
Infant, Very Low Birth Weight
Interventions
Other: 60 Seconds of placental blood transfusion
Other: 30 Seconds of placental blood transfusion
First Posted Date
2015-06-23
Last Posted Date
2019-10-30
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
105
Registration Number
NCT02478684
Locations
🇺🇸

Weill Cornell medical College, New York, New York, United States

KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

Phase 1
Completed
Conditions
Diffuse Large B-Cell Lymphoma
Interventions
First Posted Date
2015-06-15
Last Posted Date
2022-04-12
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
22
Registration Number
NCT02471911
Locations
🇺🇸

Weill Cornell Medical College, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath